Obal Detlef, Wu Joseph C
Stanford Cardiovascular Institute, Stanford University, Stanford, California, USA.
Department of Anesthesiology, Pain, and Perioperative Medicine, Stanford University, Stanford, California, USA.
Br J Pharmacol. 2020 Oct;177(20):4581-4594. doi: 10.1111/bph.15228. Epub 2020 Aug 27.
Recent advances in human induced pluripotent stem cell (iPSC) technology may provide unprecedented opportunities to study patient-specific responses to anaesthetics and opioids. In this review, we will (1) examine the advantages and limitations of iPSC technology, (2) summarize studies using iPSCs that have contributed to our current understanding of anaesthetics and opioid action on the cardiovascular system and central nervous system (CNS), and (3) describe how iPSC technology can be used to further develop personalized analgesic and sedative pharmacotherapies with reduced or minimal detrimental cardiovascular effects.
人类诱导多能干细胞(iPSC)技术的最新进展可能为研究患者对麻醉剂和阿片类药物的特异性反应提供前所未有的机会。在本综述中,我们将:(1)探讨iPSC技术的优势和局限性;(2)总结使用iPSC的研究,这些研究有助于我们目前对麻醉剂和阿片类药物对心血管系统和中枢神经系统(CNS)作用的理解;(3)描述如何利用iPSC技术进一步开发具有减少或最小有害心血管影响的个性化镇痛和镇静药物疗法。